Free Trial

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Reaches New 1-Year Low - What's Next?

Telix Pharmaceuticals Limited American Depositary Shares logo with Medical background
Remove Ads

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Get Free Report)'s share price reached a new 52-week low during mid-day trading on Saturday . The stock traded as low as $13.61 and last traded at $13.61, with a volume of 112377 shares changing hands. The stock had previously closed at $16.15.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on TLX shares. William Blair reiterated an "outperform" rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a report on Wednesday, March 12th. UBS Group raised their price target on Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the company a "buy" rating in a report on Monday, January 27th.

Read Our Latest Analysis on TLX

Telix Pharmaceuticals Limited American Depositary Shares Trading Up 1.7 %

The company has a fifty day moving average price of $17.45.

About Telix Pharmaceuticals Limited American Depositary Shares

(Get Free Report)

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.

Read More

Should You Invest $1,000 in Telix Pharmaceuticals Limited American Depositary Shares Right Now?

Before you consider Telix Pharmaceuticals Limited American Depositary Shares, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telix Pharmaceuticals Limited American Depositary Shares wasn't on the list.

While Telix Pharmaceuticals Limited American Depositary Shares currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 International Stocks to Escape U.S. Market Volatility

5 International Stocks to Escape U.S. Market Volatility

MarketBeat’s Chris Markoch shares 5 international stock picks that could offer protection—and potential opportunity—amid the current market uncertainty.

Related Videos

3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
3 AI Stocks to Watch After NVIDIA’s Dip

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads